Citations (24)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Yoshiro Nakahara, Taku Kouro, Yuka Igarashi, Mamoru Kawahara & Tetsuro Sasada. (2019) Prospects for a personalized peptide vaccine against lung cancer. Expert Review of Vaccines 18:7, pages 703-709.
Read now
Read now
Ryuji Takahashi, Munehiro Yoshitomi, Shigeru Yutani, Takahisa Shirahama, Masanori Noguchi, Akira Yamada, Kyogo Itoh & Tetsuro Sasada. (2013) Current status of immunotherapy for the treatment of biliary tract cancer. Human Vaccines & Immunotherapeutics 9:5, pages 1069-1072.
Read now
Read now
Articles from other publishers (22)
Canling Lin, Yonghui Chen, Liji Shi, Huarong Lin, Hongmei Xia & Weihua Yin. (2023) Advances in bio-immunotherapy for castration-resistant prostate cancer. Journal of Cancer Research and Clinical Oncology 149:14, pages 13451-13458.
Crossref
Crossref
Marium Husain, Luxi Chen, David Liebner, Joal Beane, Mark Rubinstein, Raphael Pollock, Claire Verschraegen & Gabriel Tinoco. (2023) Emerging Trends in Immunotherapy for Adult Sarcomas. The Oncologist 28:5, pages e233-e241.
Crossref
Crossref
Ichwaku Rastogi, Anusha Muralidhar & Douglas G. McNeel. (2023) Vaccines as treatments for prostate cancer. Nature Reviews Urology.
Crossref
Crossref
Mohsen Karami Fath, Kimiya Babakhaniyan, Maryam Zokaei, Azadeh Yaghoubian, Sadaf Akbari, Mahdieh Khorsandi, Asma Soofi, Mohsen Nabi-Afjadi, Hamidreza Zalpoor, Fateme Jalalifar, Ali Azargoonjahromi, Zahra Payandeh & Armina Alagheband Bahrami. (2022) Anti-cancer peptide-based therapeutic strategies in solid tumors. Cellular & Molecular Biology Letters 27:1.
Crossref
Crossref
Hina Qayoom, Umar Mehraj, Shariqa Aisha, Shazia Sofi & Manzoor Ahmad Mir. 2022. Drug Repurposing - Molecular Aspects and Therapeutic Applications. Drug Repurposing - Molecular Aspects and Therapeutic Applications.
Li Li, Jianhong Chen, Yue Ming, Bin Li, Ruoqiu Fu, Dongyu Duan, Ziwei Li, Rui Ni, Xianfeng Wang, Yueling Zhou & Lin Zhang. (2022) The Application of Peptides in Glioma: A Novel Tool for Therapy. Current Pharmaceutical Biotechnology 23:5, pages 620-633.
Crossref
Crossref
Manzoor A. Mir, Shazia Sofi & Hina Qayoom. 2022. Combinational Therapy in Triple Negative Breast Cancer. Combinational Therapy in Triple Negative Breast Cancer
149
176
.
Brigida Anna Maiorano, Giovanni Schinzari, Davide Ciardiello, Maria Grazia Rodriquenz, Antonio Cisternino, Giampaolo Tortora & Evaristo Maiello. (2021) Cancer Vaccines for Genitourinary Tumors: Recent Progresses and Future Possibilities. Vaccines 9:6, pages 623.
Crossref
Crossref
Remy Thomas, Ghaneya Al-Khadairi & Julie Decock. (2021) Immune Checkpoint Inhibitors in Triple Negative Breast Cancer Treatment: Promising Future Prospects. Frontiers in Oncology 10.
Crossref
Crossref
Maria Adamaki & Vassilios Zoumpourlis. (2021) Immunotherapy as a Precision Medicine Tool for the Treatment of Prostate Cancer. Cancers 13:2, pages 173.
Crossref
Crossref
Ali Sanjari-Moghaddam, Fatemeh Sadeghi & Saeed Soleyman-Jahi. 2020. Cancer Immunology. Cancer Immunology
213
240
.
Isaac Kim, Katherine Sanchez, Heather L. McArthur & David Page. (2019) Immunotherapy in Triple-Negative Breast Cancer: Present and Future. Current Breast Cancer Reports 11:4, pages 259-271.
Crossref
Crossref
Masanori Noguchi, Noriko Koga, Fukuko Moriya, Shigetaka Suekane, Shigeru Yutani, Akira Yamada, Shigeki Shichijo, Tatuyuki Kakuma & Kyogo Itoh. (2018) Survival analysis of multiple peptide vaccination for the selection of correlated peptides in urological cancers. Cancer Science 109:9, pages 2660-2669.
Crossref
Crossref
Sang Hyeon Cheon. 2018. Management of Advanced Prostate Cancer. Management of Advanced Prostate Cancer
181
187
.
Takahiro Kimura, Shin Egawa & Hirotsugu Uemura. (2017) Personalized peptide vaccines and their relation to other therapies in urological cancer. Nature Reviews Urology 14:8, pages 501-510.
Crossref
Crossref
Koichi Takayama, Shunichi Sugawara, Yasuo Saijo, Makoto Maemondo, Atsushi Sato, Shinzo Takamori, Taishi Harada, Tetsuro Sasada, Tatsuyuki Kakuma, Junji Kishimoto, Akira Yamada, Masanori Noguchi, Kyogo Itoh & Yoichi Nakanishi. (2016) Randomized Phase II Study of Docetaxel plus Personalized Peptide Vaccination versus Docetaxel plus Placebo for Patients with Previously Treated Advanced Wild Type EGFR Non-Small-Cell Lung Cancer. Journal of Immunology Research 2016, pages 1-7.
Crossref
Crossref
Yu-Feng Xiao, Meng-Meng Jie, Bo-Sheng Li, Chang-Jiang Hu, Rui Xie, Bo Tang & Shi-Ming Yang. (2015) Peptide-Based Treatment: A Promising Cancer Therapy. Journal of Immunology Research 2015, pages 1-13.
Crossref
Crossref
Uhi Toh, Tetsuro Sasada, Ryuji Takahashi, Kyogo Itoh & Yoshito Akagi. 2015. Cancer Immunology. Cancer Immunology
185
197
.
Imran Siddiqui, Alberto Mantovani & Paola Allavena. 2015. Cancer Immunology. Cancer Immunology
263
282
.
Michael R Olin, Walter Low, David H McKenna, Stephen J Haines, Tambra Dahlheimer, David Nascene, Michael P Gustafson, Allan B Dietz, H Brent Clark, Wei Chen, Bruce Blazar, John R Ohlfest & Christopher Moertel. (2014) Vaccination with dendritic cells loaded with allogeneic brain tumor cells for recurrent malignant brain tumors induces a CD4+IL17+ response. Journal for ImmunoTherapy of Cancer 2:1.
Crossref
Crossref
Cristiana Pistol Tanase. (2014) Cancer stem cells: Involvement in pancreatic cancer pathogenesis and perspectives on cancer therapeutics. World Journal of Gastroenterology 20:31, pages 10790.
Crossref
Crossref
Shigeru Yutani, Nobukazu Komatsu, Satoko Matsueda, Munehiro Yoshitomi, Takahisa Shirahama, Akira Yamada, Kyogo Itoh & Tetsuro Sasada. (2013) Juzentaihoto Failed to Augment Antigen-Specific Immunity but Prevented Deterioration of Patients’ Conditions in Advanced Pancreatic Cancer under Personalized Peptide Vaccine. Evidence-Based Complementary and Alternative Medicine 2013, pages 1-10.
Crossref
Crossref